Ola Electric Mobility Regulatory Approval

Capital Structure Change

Ola Electric Mobility Capital Structure Change

Ola Electric confirmed two Specific Investors applied 23,855,476 rights entitlements in its partly paid-up shares rights issue. This is a Regulation 77B(2) application confirmation.

Other Announcement

Ola Electric Mobility Other Announcement

Ola Electric Mobility Ltd has filed its shareholding pattern for the quarter ended September 30, 2026, as per regulatory requirements.

Business Update

Ola Electric Mobility Business Update

Ola Electric's Promoter and CMD tweeted about onboarding the first 150 dealers. This social media communication highlights the company's network expansion and dealer engagement initiatives.

onboarded dealers

150.0 dealers

Fund RaiseAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Ola Electric Mobility Fund Raise of ₹999.7 Cr

Ola Electric Mobility Limited approved a rights issue of 370.27 million equity shares at Rs. 27 per share to raise Rs. 999.74 Crore.

Value

₹999.7 Cr

Capital Structure Change

Ola Electric Mobility Capital Structure Change

Ola Electric will raise ₹999.74 Crore via a rights issue of 37.03 crore shares at ₹27 each. The record date is October 13, 2026.

Value

₹999.7 Cr

Board Meeting Date

Ola Electric Mobility Board Meeting Date

Ola Electric has deferred its board meeting originally scheduled for October 5, 2026, pending receipt of in-principle approvals for its upcoming Rights Issue.

Regulatory ApprovalShalby Ltd SHALBYAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Shalby Regulatory Approval

Shalby Hospital, Jabalpur received CMHO permission to resume normal operations, including patient admissions, on its previously affected floor. The hospital has now fully resumed healthcare services.

Regulatory ApprovalElantas Beck India Ltd ELANTASAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Elantas Beck India Regulatory Approval

Elantas Beck India's GPCB permanently revoked the closure direction on its Ankleshwar plant. The facility can keep operating, subject to compliance conditions.

Regulatory ApprovalKalyani Cast-Tech Ltd 544023Alfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Kalyani Cast-Tech Regulatory Approval

Kalyani Cast-Tech received RDSO Stage-I concept design approval for its new container-carrying wagon under PWDA. Stage-II detailed design approval is still required, subject to dynamics simulation conditions.

Regulatory ApprovalMukka Proteins Ltd MUKKAAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Mukka Proteins Regulatory Approval

Mukka Proteins received a US FDA facility registration certificate, valid October 1, 2026 to December 31, 2027. The company says the registration supports its engagement with US customers and markets.

Execution

October 1, 2026 to December 31, 2027

Regulatory ApprovalCanara Bank CANBKAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Canara Bank Regulatory Approval

Canara Bank received RBI permission to exercise the call option on its Basel III AT1 bonds (ISIN INE476A08134) of Rs.1,500 Crore. The bank is now in process of exercising the call as per the issue terms.

Value

₹1,500 Cr

Regulatory ApprovalAlembic Pharmaceuticals Ltd APLLTDAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Alembic Pharmaceuticals Regulatory Approval

Alembic Pharmaceuticals received USFDA final approval for Valganciclovir for Oral Solution, 50 mg/mL. This adds to its cumulative 247 USFDA ANDA approvals.